Home › Trinity Biotech plc (TRIB) Receives "Buy" Rating from Roth Capital
 

Keywords :   


Trinity Biotech plc (TRIB) Receives "Buy" Rating from Roth Capital

2015-12-17 00:17:06| Biotech - Topix.net

's stock had its "buy" rating reiterated by equities research analysts at Roth Capital in a report issued on Wednesday, Analyst Ratings Net reports. A number of other research firms also recently issued reports on TRIB.

Tags: buy rating capital receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
More »